Amphastar Pharmaceuticals (AMPH) Amortizatization of Intangibles (2014 - 2026)

Amphastar Pharmaceuticals has reported Amortizatization of Intangibles for 10 years, with the latest figure at $2.1 million in Q2 2026.

• On a quarterly basis, Amortizatization of Intangibles rose 32.41% year-over-year to $2.1 million in Q2 2026; TTM through Jun 2026 was $7.6 million, a 38.23% increase from a year earlier, with the FY2025 full-year figure at $6.5 million, up 53.52% from the prior year.
• Amortizatization of Intangibles was $2.1 million for Q2 2026 at Amphastar Pharmaceuticals, roughly flat from $2.1 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $2.1 million in Q2 2026, with the low at $828000.0 in Q1 2022.
• Average Amortizatization of Intangibles over 5 years is $1.2 million, with a median of $988500.0 recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Amortizatization of Intangibles dropped 4.06% in 2022, then surged 63.06% in 2025.
• Over 5 years, Amortizatization of Intangibles stood at $902000.0 in 2022, then advanced by 6.87% to $964000.0 in 2023, then increased by 27.39% to $1.2 million in 2024, then soared by 34.04% to $1.6 million in 2025, then soared by 30.56% to $2.1 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $2.1 million (Q2 2026), $2.1 million (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.